Cargando…

Identification and Validation of a Novel Prognostic Gene Model for Colorectal Cancer

AIMS: Colon cancer (CRC), with high morbidity and mortality, is a common and highly malignant cancer, which always has a bad prognosis. So it is urgent to employ a reasonable manner to assess the prognosis of patients. We developed and validated a gene model for predicting CRC risk. METHODS: The Gen...

Descripción completa

Detalles Bibliográficos
Autores principales:	Meng, Yan, Zhou, Rulin, Lin, Zhizhao, Peng, Qun, Ding, Jian, Huang, Mei, Li, Yiwen, Guo, Xuxue, Zhuang, Kangmin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2022
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9343208/ https://www.ncbi.nlm.nih.gov/pubmed/35924107 http://dx.doi.org/10.1155/2022/9774219

Ejemplares similares

Pan-Cancer Analysis of the Oncogenic and Immunological Role of RCN3: A Potential Biomarker for Prognosis and Immunotherapy
por: Ding, Jian, et al.
Publicado: (2022)

Identification and validation of a novel stress granules-related prognostic model in colorectal cancer
por: Liu, Zhihao, et al.
Publicado: (2023)

Identification and validation of potential novel prognostic biomarkers for patients with glioma based on a gene co-expression network
por: Jiang, Yan-Wei, et al.
Publicado: (2020)

Comprehensive analysis of the prognosis and immune effect of the oncogenic protein Four Jointed Box 1
por: Huang, Mei, et al.
Publicado: (2023)

Identification and validation of a novel signature as a diagnostic and prognostic biomarker in colorectal cancer
por: Wang, Di, et al.
Publicado: (2022)

Identification and Validation of Potential Pathogenic Genes and Prognostic Markers in ESCC by Integrated Bioinformatics Analysis
por: Tang, Lu, et al.
Publicado: (2020)

A pan-cancer analysis of thioredoxin-interacting protein as an immunological and prognostic biomarker
por: Guo, Xuxue, et al.
Publicado: (2022)

Identification and Clinical Validation of a Novel 4 Gene-Signature with Prognostic Utility in Colorectal Cancer
por: Ahluwalia, Pankaj, et al.
Publicado: (2019)

Identification and validation of m6A-GPI signatures as a novel prognostic model for colorectal cancer
por: Ma, Bin, et al.
Publicado: (2023)

Identification and validation of immunotherapy for four novel clusters of colorectal cancer based on the tumor microenvironment
por: Zheng, Xiaoyong, et al.
Publicado: (2022)

Derivation and Clinical Validation of a Redox-Driven Prognostic Signature for Colorectal Cancer
por: Dang, Qin, et al.
Publicado: (2021)

Identification and Validation of EMT-Related lncRNA Prognostic Signature for Colorectal Cancer
por: Li, Danfeng, et al.
Publicado: (2021)

Identification and Validation of Six Autophagy-related Long Non-coding RNAs as Prognostic Signature in Colorectal Cancer
por: Cheng, Lin, et al.
Publicado: (2021)

Identification of NEO1 as a prognostic biomarker and its effects on the progression of colorectal cancer
por: Zhang, Meng, et al.
Publicado: (2020)

Identification and Validation of a Novel RNA-Binding Protein-Related Gene-Based Prognostic Model for Multiple Myeloma
por: Wang, Wei, et al.
Publicado: (2021)

Identification of a prognostic signature and ENTR1 as a prognostic biomarker for colorectal mucinous adenocarcinoma
por: Huang, An, et al.
Publicado: (2023)

Discovery and Validation of a Novel Metastasis-Related lncRNA Prognostic Signature for Colorectal Cancer
por: Tang, Qiang, et al.
Publicado: (2022)

Identification and Validation of Immune- and Stemness-Related Prognostic Signature of Melanoma
por: Zhang, Yan, et al.
Publicado: (2021)

ABCD3 is a prognostic biomarker for glioma and associated with immune infiltration: A study based on oncolysis of gliomas
por: Li, Jinchuan, et al.
Publicado: (2022)

Identification and Validation of Novel Serum Autoantibody Biomarkers for Early Detection of Colorectal Cancer and Advanced Adenoma
por: Wang, Hejing, et al.
Publicado: (2020)

Identification and validation of PSAT1 as a potential prognostic factor for predicting clinical outcomes in patients with colorectal carcinoma
por: Qian, Cheng, et al.
Publicado: (2017)

Identification and Validation of PLOD2 as an Adverse Prognostic Biomarker for Oral Squamous Cell Carcinoma
por: Sun, Yawei, et al.
Publicado: (2021)

Development and Clinical Validation of a Novel 4-Gene Prognostic Signature Predicting Survival in Colorectal Cancer
por: Yuan, Yihang, et al.
Publicado: (2020)

Identification and validation of novel prognostic biomarkers and therapeutic targets for non-small cell lung cancer
por: Lai, Li-Ting, et al.
Publicado: (2023)

Identification and Validation of lncRNA-AC087588.2 in Lung Adenocarcinoma: A Novel Prognostic and Diagnostic Indicator
por: Jiang, Xiulin, et al.
Publicado: (2022)

CDK5 functions as a tumor promoter in human colorectal cancer via modulating the ERK5–AP-1 axis
por: Zhuang, Kangmin, et al.
Publicado: (2016)

Development and validation of an online calculator to predict the pathological nature of colorectal tumors
por: Wang, Ya-Dan, et al.
Publicado: (2023)

Identification and Validation of Immune Cells and Hub Genes in Gastric Cancer Microenvironment
por: Wang, Huan, et al.
Publicado: (2022)

Identification of Tumorigenic and Prognostic Biomarkers in Colorectal Cancer Based on microRNA Expression Profiles
por: Shi, Yuntao, et al.
Publicado: (2020)

Development and Validation of a Novel Prognostic Nomogram Combined With Desmoplastic Reaction for Synchronous Colorectal Peritoneal Metastasis
por: Qin, Xiusen, et al.
Publicado: (2022)

Identification and validation of obesity-related gene LEP methylation as a prognostic indicator in patients with acute myeloid leukemia
por: Zhang, Ting-juan, et al.
Publicado: (2021)

Identification and Validation of Novel Immune-Related Alternative Splicing Signatures as a Prognostic Model for Colon Cancer
por: Liu, Yunze, et al.
Publicado: (2022)

Identification and validation of a novel necroptosis-related prognostic signature in cervical squamous cell carcinoma and endocervical adenocarcinoma
por: Zhang, Weiyu, et al.
Publicado: (2022)

Identification and validation of NFIA as a novel prognostic marker in renal cell carcinoma
por: de Alwis, Roger, et al.
Publicado: (2023)

Identification and validation of DPY30 as a prognostic biomarker and tumor immune microenvironment infiltration characterization in esophageal cancer
por: Mei, Pei-Yuan, et al.
Publicado: (2022)

Development and validation of a prognostic 9-gene signature for colorectal cancer
por: Cui, Junpeng, et al.
Publicado: (2022)

Identification of TRPV4 as a novel target in invasiveness of colorectal cancer
por: Zhang, Peng, et al.
Publicado: (2021)

The Effect of Supervisor Identification on Unethical Pro-Supervisor Behavior: The Moderating Role of Employability Perceptions
por: Lee, Kangmin
Publicado: (2020)

Identification of a novel prognostic signature correlated with epithelial‐mesenchymal transition, N6‐methyladenosine modification, and immune infiltration in colorectal cancer
por: Qu, Xiao, et al.
Publicado: (2022)

Identification and validation of inferior prognostic genes associated with immune signatures and chemotherapy outcome in acute myeloid leukemia
por: Wang, Jie, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_dq4m4rbdo6d44dgjpvjkj1um3q